Karen L. Tubridy serves as Executive at Eleven Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Karen L. Tubridy has executed 10 insider transactions totaling $51.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 28, 2020 involved receiving (via award) 30,000 shares valued at $0.
Karen L. Tubridy currently holds 88,133 shares of Eleven Biotherapeutics, Inc. (EBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen L. Tubridy has been a net seller of EBIO stock. They have purchased $0 and sold $51.8K worth of shares.
Karen L. Tubridy's most recent insider trade was on Feb 28, 2020, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.70 |
| Discretionary |
| Apr 11, 2019 | AKBA | $46.8K | Disposition | 6,075 | $7.70 | Discretionary |
| Feb 28, 2019 | AKBA | $0 | Award | 30,000 | $N/A | Discretionary |
| Dec 12, 2018 | AKBA | $106.6K | Payment | 11,928 | $8.94 | Discretionary |
| Feb 28, 2018 | AKBA | $0 | Award | 17,500 | $N/A | Discretionary |
| Feb 21, 2017 | AKBA | $0 | Award | 23,000 | $N/A | Discretionary |
| Jun 27, 2016 | EBIO | $9.1K | Sale | 4,372 | $2.08 | Discretionary |
| Dec 28, 2015 | EBIO | $12.6K | Sale | 4,427 | $2.85 | Discretionary |
| Jun 26, 2015 | EBIO | $0 | Award | 37,400 | $N/A | Discretionary |